Dysmenorrhea Market is Expected to Witness Increased Growth Over the Forecast Period (2022-2032), Reviews DelveInsight | Key Companies – Myovant Sciences GmbH, Takeda, Bayer, ObsEva SA, Fuji Pharma’s


The dysmenorrhea market is expected to rise owing to the rising prevalence and awareness of the disease over the forecast period. Further, the launch of various multi-stage dysmenorrhea pipeline products will significantly revolutionize the dynamics of the dysmenorrhea market.

by DelveInsight “Dysmenorrhea Market Insights, Epidemiology and Market Forecast-2032” The report offers an in-depth understanding of dysmenorrhea, historical and forecast epidemiology as well as dysmenorrhea market trends in the US, EU5 (Germany, Spain, Italy, France, and UK) and the Japan.

Overview of Dysmenorrhea

Painful menstruation in medical terms is described as dysmenorrhea, often referred to as “menstrual cramps” in simpler terms. Dysmenorrhea can be classified into two types: primary dysmenorrhea and secondary dysmenorrhea. Primary dysmenorrhea is a common menstrual cramp related to the normal process of menstruation. Whereas, in secondary dysmenorrhea, the pain is caused by any disorder in the female reproductive organs.

Some of the key facts from the Dysmenorrhea Market report:

  • The dysmenorrhea market size was valued at $7.7 billion in 2019 and is expected to grow with a significant CAGR over the study period (2019-2032)
  • In 2019, the total number of prevalent cases of dysmenorrhea was 134,928,831 cases in the 7MM
  • The United States accounted for nearly 43% of total 7MM cases in 2019
  • Among the EU-5 countries, the highest number of dysmenorrhea cases were in Germany, i.e.13,162,395 cases in 2019, which is expected to increase by 2032
  • Orilissa (elagolix) from AbbVie and Neurocrine Biosciencesis the first and only orally administered non-peptide small molecule GnRH antagonist that is specifically developed for women with moderate to severe endometriotic pain
  • Key Dysmenorrhea Companies: Myovant Sciences GmbH, Takeda, Bayer, ObsEva SA, Fuji Pharma’s, Laboratorios Andromaco SA, Juniper Pharmaceuticals, Inc. and others
  • Key therapies for dysmenorrhea: Relugolix, Yselty, FSN-013, LEP, Meloxicam, Lidocaine and others

Get Free Sample For Dysmenorrhea Market Report

Key Benefits of the Dysmenorrhea Market Report:

  1. The Dysmenorrhea Market report covers a descriptive overview and comprehensive overview of the Dysmenorrhea and Dysmenorrhea Epidemiology Market in 7MM (US, EU5 (Germany, Spain, France, Italy, UK ) and Japan.)
  2. The Dysmenorrhea market report provides information on current and emerging therapies.
  3. The Dysmenorrhea Market report provides historical and forecasted global market covering the diffusion of drugs in 7MM.
  4. The Dysmenorrhea Market report provides an advantage which will help in developing business strategies by understanding the trends shaping and driving the Dysmenorrhea market.

Learn more about Therapies set to capture major Dysmenorrhea Market Share @ Dysmenorrhea Market Forecast

Segmentation of dysmenorrhea epidemiology:

The Dysmenorrhea Market report offers epidemiological analysis for the study period 2019-2032 in 7MM segmented into:

  • Total prevalence of dysmenorrhea
  • Prevalent cases of dysmenorrhea by severity
  • Prevalence of dysmenorrhea by sex
  • Diagnosed cases of episodic and chronic dysmenorrhea

Dysmenorrhea Market

Dysmenorrhea market dynamics are expected to change in the coming years owing to the anticipated launch of emerging therapies such as Yselty, FSN-013, and others during the forecast period 2019-2032.

Download the report to understand what factors drive epidemiological trends in dysmenorrhea @ Dysmenorrhea Epidemiological Insights

Dysmenorrhea Market Drivers

  • Increase in prevalence due to increased awareness and lifestyle changes
  • Emerging landscape with promising first signs of effectiveness

Dysmenorrhea therapies and key companies

Relugolix: Myovant Sciences GmbH/Takeda

  • Yselty: ObsEva SA
  • FSN-013: Fuji Pharma
  • THE P : Bayer
  • Meloxicam: Andromaco Laboratories SA
  • Lidocaine: Juniper Pharmaceuticals, Inc.

Scope of the Dysmenorrhea Market Report

  • Study period: 2019-2032
  • Cover: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Dysmenorrhea Companies: Myovant Sciences GmbH, Takeda, Bayer, ObsEva SA, Fuji Pharma’s, Laboratorios Andromaco SA, Juniper Pharmaceuticals, Inc. and others
  • Key therapies for dysmenorrhea: Relugolix, Yselty, FSN-013, LEP, Meloxicam, Lidocaine and others
  • Therapeutic assessment of dysmenorrhea: Currently marketed therapies for dysmenorrhea and emerging therapies for dysmenorrhea
  • Dysmenorrhea Market Dynamics: Dysmenorrhea Market Drivers and Dysmenorrhea Market Barriers
  • Competitive intelligence analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG matrix, market entry strategies
  • Dysmenorrhea Unmet Needs, KOL Views, Analyst Views, Market Access and Dysmenorrhea Reimbursement

Dysmenorrhea Market Barriers

  • Limitations of current therapies such as side effects and poor efficacy
  • The anticipated growing use of generics


1. Overview of the Dysmenorrhea Market Report

2. Executive Summary for Dysmenorrhea

3. SWOT Analysis of Dysmenorrhea

4. Share of Dysmenorrhea Patients (%) Overview at a Glance

5. Dysmenorrhea Market Overview at a Glance

6. Background and overview of dysmenorrhea

7. Dysmenorrhea epidemiology and patient population

8. Country-specific dysmenorrhea patient population

9. Current Dysmenorrhea Treatment and Medical Practices

10. Dysmenorrhea Unmet Needs

11. Emerging therapies for dysmenorrhea

12. Dysmenorrhea Market Outlook

13. Dysmenorrhea Market Analysis by Countries (2019-2032)

14. Access to the dysmenorrhea market and reimbursement of therapies

15. Dysmenorrhea Market Drivers

16. Dysmenorrhea Market Barriers

17. Dysmenorrhea Appendix

18. Dysmenorrhea reporting methodology

19. DelveInsight Abilities

20. Disclaimer

21. About DelveInsight

To learn more about treating dysmenorrhea, visit @ Dysmenorrhea Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Gaurav Bora
E-mail: Send an email
Call: 9193216187
Address:304 S. Jones Boulevard #2432
Town: Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/


About Author

Comments are closed.